Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

This study has been terminated.

( Unable to accrue patients to the study. )

Study NCT00006262 Information provided by Northwestern University

First Received: September 11, 2000 Last Updated: February 16, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2001
Primary Completion Date:	September 2001 (Final data collection date for primary outcome measure)